About Sooam Biotech Research Foundation
Sooam Biotech, based in South Korea, is one of the most historically significant and controversial names in the pet cloning world. Founded by Dr. Hwang Woo-suk, a prominent stem cell researcher, Sooam was one of the first institutions to offer commercial dog cloning and has cloned hundreds of dogs since its inception. The company positions itself at the intersection of science, ethics, and emotion recreating pets that owners have deeply bonded with.
Despite past controversies surrounding its founder, Sooam has maintained a reputation for technical excellence and high cloning success rates. Its operations are research-driven, and the facility also conducts genetic engineering and endangered species preservation projects, further validating its scientific capabilities.
Services
Dog Cloning: Creates a genetically identical dog using somatic cell nuclear transfer (SCNT) with high precision and success rates.
DNA Banking: Offers long-term preservation of your pet's genetic material for future cloning.
Emergency Tissue Collection Support: Provides protocols and remote guidance to veterinarians worldwide for timely sample collection.
International Consultation and Delivery: Works with clients across the globe to deliver cloned pets safely and legally.
Cloning for Special Use Cases: Offers cloning for police dogs, hunting dogs, and service animals with elite training.
Strengths
Decades of specialization in dog cloning
High cloning volume demonstrates scalability and experience
Ethical oversight, including surrogate care standards
Strong track record of scientific publications and breakthroughs
Broad use cases including service and police dog cloning
Weaknesses
Premium pricing
Regulatory scrutiny due to founder’s controversy
Logistics challenges for non-Korean clients
Summary
Sooam Biotech’s cloning services are primarily available to international clients, with clear processes and consultation in English. The cloning process begins with immediate tissue preservation, ideally within 5 days of a pet’s passing or while the pet is still alive. The lab extracts viable cells and initiates SCNT, implanting the cloned embryo into a surrogate.
The company is known for its high cloning success rates and its ability to replicate rare and mixed-breed dogs. While the science is strong, Sooam's reputation has occasionally been impacted by past ethical issues related to its founder. However, clients often choose Sooam for its longstanding experience, proven outcomes, and specialization in high-performance working dogs. Many cloned dogs from Sooam are now living around the world, with visibly similar traits and mannerisms to their genetic originals.